Stocksigma LogoStocksigma Logo

Jagsonpal Completes Group Pharma Wellness Portfolio Acquisition

Jagsonpal Pharmaceuticals consummated the acquisition of Group Pharmaceuticals' Wellness Portfolio on 1st Oct'26

Jagsonpal Completes Group Pharma Wellness Portfolio Acquisition

Jagsonpal Pharmaceuticals Ltd · Others (Uncategorized) · 01 Oct 2026, 10:27 pm

Jagsonpal Completes Group Pharma Wellness Portfolio Acquisition Jagsonpal Pharmaceuticals consummated the acquisition of Group Pharmaceuticals' Wellness Portfolio on 1st Oct'26. The deal comprises an upfront consideration of ~₹23.7 Cr and maximum performance-linked deferred consideration of ~₹23.0 Cr tied to FY28 sales. The acquired business generated ~₹24.6 Cr revenue in FY26 with a ~78.0% gross margin across 6 states, led by brands Hemozink and Sudin. Supported by a ~₹170 Cr cash balance as of Q1FY27, this margin-accretive transaction advances Jagsonpal's inorganic strategy toward its ₹500 Cr revenue target by FY28.

Original exchange filing (PDF)

More announcements from Jagsonpal Pharmaceuticals Ltd

All Jagsonpal Pharmaceuticals Ltd announcements